Showing all 12 results
Arteether Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules. The oily base (refined Arachis Oil or Ethyl Oleate) ensures depot formation in the muscle.
Active Ingredient Strength (Standard) Therapeutic Role α-β Arteether 150 mg / 2 ml Adult Dose (Standard) α-β Arteether 75 mg / 1 ml Pediatric Dose Vehicle Q.S. Refined Arachis Oil / Ethyl Oleate Oily Base (Sustained Release) *Pack Sizes: Tray of 3 Ampoules (Full Course) or Box of 10 Ampoules.
Artemether 40mg Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules. The oily base ensures a depot effect for sustained release.
Active Ingredient Strength (Standard) Therapeutic Role Artemether IP/Ph.Int 40 mg / 1 ml Pediatric / Low Body Weight Dose Artemether IP/Ph.Int 80 mg / 1 ml Adult Standard Dose Vehicle Q.S. Refined Arachis Oil / Ethyl Oleate Oily Base (Depot) *Pack Sizes: Tray of 6 Ampoules or 10 Ampoules (Standard Course).
Artemether-80 Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules. The 80mg strength is specifically formulated to minimize the injection volume for adult patients while delivering a potent therapeutic dose.
Active Ingredient Strength (Adult Dose) Therapeutic Role Artemether IP/Ph.Int 80 mg Potent Antimalarial Vehicle Q.S. to 1 ml Refined Arachis Oil / Ethyl Oleate *Pack Sizes: Tray of 6 Ampoules or 10 Ampoules (Standard Adult Course).
Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Artesunate & Mefloquine Tablet
FreeProduct Composition & Compliance Configurations
We supply this combination in both co-formulated Fixed-Dose Combination (FDC) single tablets and customized, color-coded co-blistered kits calibrated for adult and pediatric treatment regimens.
Product Packaging Format Active Ingredient Mix (per Dose) Target Patient Cohort Primary Clinical Function Pediatric Compliance FDC 25 mg Artesunate + 55 mg Mefloquine Infants & Children (6 months to less than 7 years) Micro-Dose Accuracy: Optimized for easy pediatric disintegration and ingestion. Adolescent Strength FDC 100 mg Artesunate + 220 mg Mefloquine Youth & Teenagers (7 years to less than 14 years) Intermediate Titration: Ensures balanced dosing without neuro-toxicity risks. Adult Potency FDC / Kit 100 mg + 220 mg (2 Tablets/Day for 3 days) or 200 mg + 440 mg Adults & Children over 14 years Full Strength Treatment: Maximizes biomass eradication in multi-drug resistant zones. Artesunate & Sulphadoxine-Pyrimethamine Tablets
FreeProduct Composition & Kit Configuration
We supply this product in standardized, age-titrated Fixed-Dose Combination (FDC) Blister Strips, commonly containing a 3-day course of Artesunate tablets alongside a single-dose treatment of Sulfadoxine-Pyrimethamine.
Component Tablet Type Active Ingredient Mix Standard Strengths (per Tablet) Primary Clinical Function Artesunate Tablet Artesunate 50 mg / 100 mg / 200 mg The Fast Cleaver: Clears parasite biomass over 3 consecutive days. Sulfadoxine-Pyrimethamine Tablet Sulfadoxine + Pyrimethamine 500 mg + 25 mg The Extended Shield: Single-dose companion to prevent recrudescence. Artesunate 120mg Injection
FreeProduct Composition & Strength
We supply this product as a Combi-Pack containing the Lyophilized Powder and special solvents required for activation.
Component Content Function Vial (Powder) Artesunate 120 mg (Sterile Lyophilized) Active Antimalarial Ampoule 1 Sodium Bicarbonate Injection (5%) – 1ml Activator / Solvent (Solubilizes the acid) Ampoule 2 Sodium Chloride Injection (0.9%) – 5ml Diluent (Adjusts volume/tonicity) *Pack Sizes: Single Combi-Pack or Tray of 5 Combi-Packs.
Chloroquine Phosphate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution in Amber Glass Vials/Ampoules.
Active Ingredient Salt Strength Base Equivalent Chloroquine Phosphate USP/BP 64.5 mg / ml Equivalent to 40 mg Chloroquine Base Total Vial Content 30 ml Multi-dose Vial 1200 mg Base Total Excipients Chlorocresol (Preservative) Water for Injection *Pack Sizes: Tray of 10 Ampoules (5ml) or Multi-dose Vials (30ml).
Hydroxy Chloroquine Sulfate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Heavy-Coated Tablet, packed exclusively in highly secure, light-blocking Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the photolabile active ingredient.
Active Ingredient Strength Primary Clinical Function Hydroxychloroquine Sulfate USP/Ph.Eur. 200 mg Global Rheumatology Standard: Base therapeutic unit for daily chronic maintenance in SLE and RA, allowing for exact mg/kg dosing based on ideal body weight to prevent toxicity. Excipients Dibasic Calcium Phosphate / Pregelatinized Starch / Magnesium Stearate / Polyethylene Glycol / Premium Titanium Dioxide Opadry Film Diluent / Binder / Lubricant / Heavy Opacifying Film-Coating (Engineered specifically to form an impenetrable light barrier against UV degradation, while completely masking the intensely bitter taste of the sulfate salt to ensure long-term patient compliance) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict 3-to-6 month chronic rheumatology dispensing regimens).
Mefloquine Tablet
FreeProduct Composition & Configuration
We supply Mefloquine Hydrochloride in the internationally standardized strength calibrated for both adult therapeutic clearance and weekly travel prophylaxis.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Mefloquine Hydrochloride IP / BP / USP 250 mg
(Equivalent to 228 mg Mefloquine Base)
Oral Solid Uncoated Tablet (Cross-scored for exact pediatric dividing) Dual-Mode Antimalarial: High-dose 3-day treatment for active clearance, or low-dose once-weekly regimen for traveler chemoprophylaxis. Excipients Pharma Grade Microcrystalline Cellulose, Lactose, Magnesium Stearate The Disintegration Core: Engineered for uniform mechanical compression and rapid disintegration. Quinine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Pale Yellow Aqueous Solution in glass ampoules.
Active Ingredient Concentration Total Content & Format Quinine Dihydrochloride BP 300 mg / ml 600 mg in 2 ml Glass Ampoule Excipients Water for Injection Preservative-Free Solution *Pack Sizes: Tray of 10 Ampoules or Box of 100 Ampoules.
Sulfadoxine Pyrimethamine Tablets
FreeGomaxine
Sulfadoxine and Pyrimethamine tablets USP
Each Uncoated tablet contains :
Sulfadoxine USP 500 mg
Pyrimethamine USP 25 mgSULPHADOXINE 7 PYRIMETHAMINE TABLETS IP Each uncoated tablet contains: Sulphadoxine IP 125 mg Pyrimethamine IP 6.25 mg Excipients q.s.
Usage: – treat malaria
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
